Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ga-68-DOTATOC PET in Pituitary Tumours
NCT02419664Phase 3Terminated
- Sponsor
- University of Gothenburg
- Start
- Jan 2015
- Primary completion
- Jan 2022
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial, sponsored by University of Gothenburg. Primary endpoint: Standardised Uptake Value max at 36 months. Started Jan 2015; status: terminated.
Beyond the preview
Go deeper on NCT02419664.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02419664.